Clinical Trial Update: Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the HyperQ signal for detecting myocardial ischemia during dobutamine-stressed ECG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Drugs mentioned

• Dobutamine (dobutamine)

Snippet

Sponsor: BSP Biological Signal Processing Ltd. | Conditions: Myocardial Ischemia | Phase 3 | Status: UNKNOWN